{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:44:53Z","timestamp":1783691093802,"version":"3.55.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003825","name":"Hungarian Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003827","name":"Nemzeti Kutat\u00e1si Fejleszt\u00e9si \u00e9s Innov\u00e1ci\u00f3s Hivatal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003827","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.seminoncol.2026.152469","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:26:55Z","timestamp":1768609615000},"page":"152469","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["DNA methylation-mediated extracellular matrix gene silencing in colorectal cancer"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4129-4589","authenticated-orcid":false,"given":"Ot\u00edlia","family":"Menyhart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalma","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bal\u00e1zs","family":"Gy\u0151rffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seminoncol.2026.152469_bib0001","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","article-title":"Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN","volume":"72","author":"Morgan","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0002","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0003","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.hoc.2022.02.005","article-title":"Colorectal cancer in younger adults","volume":"36","author":"Dharwadkar","year":"2022","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0004","first-page":"233","article-title":"Colorectal cancer statistics","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0005","article-title":"Overall and stage-specific survival of patients with screen-detected colorectal cancer in European countries: a population-based study in 9 countries","volume":"21","author":"Cardoso","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0006","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41698-023-00353-4","article-title":"Survival improvement for patients with metastatic colorectal cancer over twenty years","volume":"7","author":"Zeineddine","year":"2023","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0007","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1186\/s12885-020-07656-w","article-title":"Prediction of mortality in metastatic colorectal cancer in a real-life population: a multicenter explorative analysis","volume":"20","author":"Rumpold","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0008","first-page":"11","article-title":"Cancer statistics","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0009","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41586-022-05402-9","article-title":"Metastatic recurrence in colorectal cancer arises from residual EMP1(+) cells","volume":"611","author":"Ca\u00f1ellas-Socias","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0010","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1463-1318.2010.02539.x","article-title":"Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: a population-based series","volume":"14","author":"van der Pool","year":"2012","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0011","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/1878-0261.12018","article-title":"Determinants of metastatic competency in colorectal cancer","volume":"11","author":"Tauriello","year":"2017","journal-title":"Mol Oncol"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0012","first-page":"735","article-title":"Microsatellite instability in colorectal cancer: overview of its clinical significance and novel perspectives","volume":"16","author":"Battaglin","year":"2018","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0013","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in microsatellite-instability\u2013high advanced colorectal cancer","volume":"383","author":"Andr\u00e9","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0014","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1200\/JCO.2017.76.9901","article-title":"Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient\/microsatellite instability-high metastatic colorectal cancer","volume":"36","author":"Overman","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0015","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41575-019-0126-x","article-title":"Immunotherapy in colorectal cancer: rationale, challenges and potential","volume":"16","author":"Ganesh","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0016","doi-asserted-by":"crossref","first-page":"11","DOI":"10.23922\/jarc.2020-064","article-title":"Immunotherapy in colorectal cancer: current and future strategies","volume":"5","author":"Ooki","year":"2021","journal-title":"J Anus Rectum Colon"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0017","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.3748\/wjg.v13.i12.1767","article-title":"Microsatellite instability and MLH1 promoter hypermethylation in colorectal cancer","volume":"13","author":"Niv","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0018","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2024.13278","article-title":"Research progress of DNA methylation in colorectal cancer (Review)","volume":"30","author":"Wang","year":"2024","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0019","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41575-019-0230-y","article-title":"Epigenetics of colorectal cancer: biomarker and therapeutic potential","volume":"17","author":"Jung","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0020","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ccr.2014.07.028","article-title":"Gene body methylation can alter gene expression and is a therapeutic target in cancer","volume":"26","author":"Yang","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0021","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1126\/science.1083558","article-title":"Induction of tumors in mice by genomic hypomethylation","volume":"300","author":"Gaudet","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0022","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/gutjnl-2023-329492","article-title":"Precancerous nature of intestinal metaplasia with increased chance of conversion and accelerated DNA methylation","volume":"73","author":"Takeuchi","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0023","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.3390\/ijms16022472","article-title":"Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer","volume":"16","author":"Ng","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0024","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1042\/BCJ20210084","article-title":"The roles of epigenetics in cancer progression and metastasis","volume":"478","author":"Chen","year":"2021","journal-title":"Biochem J"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0025","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.trecan.2021.11.008","article-title":"Epigenetic basis and targeting of cancer metastasis","volume":"8","author":"Banerjee","year":"2022","journal-title":"Trends Cancer"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0026","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1053\/j.gastro.2016.08.001","article-title":"Epigenetic homogeneity within colorectal tumors predicts shorter relapse-free and overall survival times for patients with locoregional cancer","volume":"151","author":"Mart\u00ednez-Card\u00fas","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0027","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1126\/science.aao3791","article-title":"Single-cell multiomics sequencing and analyses of human colorectal cancer","volume":"362","author":"Bian","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0028","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nrgastro.2011.173","article-title":"Epigenetics and colorectal cancer","volume":"8","author":"Lao","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0029","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4254862","article-title":"Meta-analysis of the prognostic and predictive role of the CpG island methylator phenotype in colorectal cancer","volume":"2022","author":"Wang","year":"2022","journal-title":"Dis Markers"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0030","doi-asserted-by":"crossref","unstructured":"D M\u00fcller, B Gy\u0151rffy, EpigenPlot: an interactive web platform for DNA methylation-based biomarker and drug target discovery in colorectal cancer. Br J Pharmacol. https:\/\/doi.org\/10.1111\/bph.17455.","DOI":"10.1111\/bph.17455"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0031","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/1471-2164-14-293","article-title":"A data-driven approach to preprocessing Illumina 450K methylation array data","volume":"14","author":"Pidsley","year":"2013","journal-title":"BMC Genomics"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0032","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/bioinformatics\/bts680","article-title":"A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450k DNA methylation array data","volume":"29","author":"Teschendorff","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0033","doi-asserted-by":"crossref","first-page":"C762","DOI":"10.1152\/ajpcell.00022.2022","article-title":"Epigenetic regulation and targeting of ECM for cancer therapy","volume":"322","author":"Gupta","year":"2022","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0034","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1038\/s41467-020-18794-x","article-title":"Concepts of extracellular matrix remodelling in tumour progression and metastasis","volume":"11","author":"Winkler","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0035","first-page":"425","article-title":"DNA methylation and colorectal cancer","volume":"10","author":"Ashktorab","year":"2014","journal-title":"Curr Colorectal Cancer Rep"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0036","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1242\/dev.01037","article-title":"Collagen IV is essential for basement membrane stability but dispensable for initiation of its assembly during early development","volume":"131","author":"P\u00f6schl","year":"2004","journal-title":"Development"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0037","doi-asserted-by":"crossref","first-page":"856","DOI":"10.2353\/ajpath.2006.050384","article-title":"Loss of expression of type IV collagen alpha5 and alpha6 chains in colorectal cancer associated with the hypermethylation of their promoter region","volume":"168","author":"Ikeda","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0038","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1007\/s10620-019-05908-9","article-title":"High-yield methylation markers for stool-based detection of colorectal cancer","volume":"65","author":"Liu","year":"2020","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0039","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s12032-013-0695-4","article-title":"Detection of hypermethylated fibrillin-1 in the stool samples of colorectal cancer patients","volume":"30","author":"Guo","year":"2013","journal-title":"Med Oncol"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0040","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/657570","article-title":"Detection of SNCA and FBN1 methylation in the stool as a biomarker for colorectal cancer","volume":"2015","author":"Li","year":"2015","journal-title":"Dis Markers"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0041","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jmoldx.2013.03.004","article-title":"Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer","volume":"15","author":"Oh","year":"2013","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0042","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1158\/1055-9965.EPI-17-0153","article-title":"Stool DNA test of methylated syndecan-2 for the early detection of colorectal neoplasia","volume":"26","author":"Niu","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0043","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13148-019-0642-0","article-title":"Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA","volume":"11","author":"Han","year":"2019","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0044","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0200735","article-title":"The importance of stool DNA methylation in colorectal cancer diagnosis: a meta-analysis","volume":"13","author":"Mojtabanezhad Shariatpanahi","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0045","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s10120-018-0866-2","article-title":"ADAMTS5 acts as a tumor suppressor by inhibiting migration, invasion and angiogenesis in human gastric cancer","volume":"22","author":"Huang","year":"2019","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0046","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/ijc.24108","article-title":"Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker","volume":"124","author":"Sadr-Nabavi","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0047","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1158\/1078-0432.CCR-07-0015","article-title":"Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation","volume":"13","author":"Yue","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0048","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1111\/jcmm.12394","article-title":"Epigenetic regulation of EFEMP1 in prostate cancer: biological relevance and clinical potential","volume":"18","author":"Almeida","year":"2014","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0049","doi-asserted-by":"crossref","first-page":"336","DOI":"10.4149\/neo_2018_180703N441","article-title":"FBLN3 inhibited the invasion and metastasis of colorectal cancer through the AKT\/mTOR pathway","volume":"66","author":"Mao","year":"2019","journal-title":"Neoplasma"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0050","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13046-022-02271-y","article-title":"Colorectal cancer development is affected by the ECM molecule EMILIN-2 hinging on macrophage polarization via the TLR-4\/MyD88 pathway","volume":"41","author":"Andreuzzi","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0051","first-page":"1043","article-title":"Expression and hypermethylation of JAM and EPB41L3 in cervical squamous cell carcinoma: clinical significance and applications","volume":"39","author":"Gu","year":"2024","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0052","first-page":"2665","article-title":"Epigenetic inactivation of laminin-5-encoding genes in lung cancers","volume":"9","author":"Sathyanarayana","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0053","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41392-019-0095-0","article-title":"Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials","volume":"4","author":"Cheng","year":"2019","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0054","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1158\/0008-5472.CAN-15-2306","article-title":"Lysyl oxidase, a targetable secreted molecule involved in cancer metastasis","volume":"76","author":"Cox","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0055","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3389\/fonc.2019.00927","article-title":"Targeting LOX-1 inhibits colorectal cancer metastasis in an animal model","volume":"9","author":"Murdocca","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0056","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41417-020-00279-0","article-title":"LOX-1 and cancer: an indissoluble liaison","volume":"28","author":"Murdocca","year":"2021","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0057","first-page":"720","article-title":"Detection of colorectal neoplasm using promoter methylation of ITGA4, SFRP2, and p16 in stool samples: a preliminary report in Korean patients","volume":"57","author":"Chang","year":"2010","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0058","doi-asserted-by":"crossref","first-page":"Fso583","DOI":"10.2144\/fsoa-2020-0034","article-title":"ITGA4 gene methylation status in chronic lymphocytic leukemia","volume":"6","author":"Attia","year":"2020","journal-title":"Future Sci OA"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0059","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1038\/s41598-021-81851-y","article-title":"Abnormal promoter DNA hypermethylation of the integrin, nidogen, and dystroglycan genes in breast cancer","volume":"11","author":"Strelnikov","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.seminoncol.2026.152469_bib0060","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1038\/sj.onc.1207470","article-title":"Aberrant methylation of integrin \u03b14 gene in human gastric cancer cells","volume":"23","author":"Park","year":"2004","journal-title":"Oncogene"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775426000163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775426000163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T08:41:24Z","timestamp":1774946484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775426000163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0093775426000163"],"URL":"https:\/\/doi.org\/10.1016\/j.seminoncol.2026.152469","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNA methylation-mediated extracellular matrix gene silencing in colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seminoncol.2026.152469","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152469"}}